PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

In recent years, immunotherapies, such as those involving chimeric antigen receptor (CAR) T cells, have become increasingly promising approaches to non-small-cell lung cancer (NSCLC) treatment. In this study, we explored the antitumor potential of prostate stem cell antigen (PSCA)-redirected CAR T a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Wei, Xinru, Lai, Yunxin, Li, Jin, Qin, Le, Xu, Youdi, Zhao, Ruocong, Li, Baiheng, Lin, Simiao, Wang, Suna, Wu, Qiting, Liang, Qiubin, Peng, Muyun, Yu, Fenglei, Li, Yangqiu, Zhang, Xuchao, Wu, Yilong, Liu, Pentao, Pei, Duanqing, Yao, Yao, Li, Peng
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384358/
https://ncbi.nlm.nih.gov/pubmed/28405515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1284722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados